SCHEDULE 13D

Company

ORAMED PHARMACEUTICALS INC.

Filed

January 6, 2016

Accession Number

0001079973-16-000726

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →